MERCK'S GARDASIL MAY GIVE WIDER CANCER PROTECTION AND GLAXOSMITHKLINE'S VACCINE "COULD CUT CERVICAL CANCER DEATHS 76 PCT"

The world's first cervical cancer vaccine may give wider protection against the killer disease than previously thought, researchers said on Sunday. New data presented at a medical conference in Prague showed Merck & Co Inc's Gardasil had the potential to neutralise additional strains of the sexually transmitted human papillomavirus (HPV) that causes the disease. Gardasil is already approved for sale in the United States and is awaiting approval in Europe.
Financial News USA